• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床药师在多学科重症监护病房中的影响。

Impact of a clinical pharmacist in a multidisciplinary intensive care unit.

作者信息

Montazeri M, Cook D J

机构信息

Department of Pharmacy, St. Joseph's Hospital, Hamilton, Ont.

出版信息

Crit Care Med. 1994 Jun;22(6):1044-8. doi: 10.1097/00003246-199406000-00027.

DOI:10.1097/00003246-199406000-00027
PMID:8205814
Abstract

OBJECTIVES

To describe the activities of a clinical intensive care unit (ICU) pharmacist and to determine whether pharmacist-initiated consultations lead to changes in drug costs.

DESIGN

Prospective, 3-month study.

SETTING

A 15-bed, university-affiliated, tertiary care medical-surgical ICU.

INTERVENTIONS

The following ICU pharmacist activities were recorded: providing drug information for physician inquiries; providing drug information for nurse inquiries; clarification of drug orders; drug accessibility information; pharmacokinetic consultation; detection and reporting of adverse drug reactions; and pharmacist-initiated therapeutic consultation leading to changes in drug therapy. When changes in drug therapy occurred, drug costs before and after the change were determined.

MEASUREMENTS AND MAIN RESULTS

During 54 weekdays, 575 pharmacist interventions occurred (10.7 +/- 5.0 interventions/day). The most common interventions were pharmacist-initiated therapeutic consultations (44.7%, 257/575 of the total), and response to physician requests for drug information (39.0%, 224/575). The most resource-intensive activities were provision of physician drug information and therapeutic consultations (49.6 mins and 35.9 mins per day, respectively). On average, 1.70 hrs (102 mins) per day were spent on all interventions. Therapeutic consultations decreased (47.1%), did not change (42.0%), or increased (10.9%) drug costs for a net savings of $10,010.60 (Canadian) over 3 months, or a projected annual savings of $67,664.24, if clinical pharmacy services were extended to 7 days/wk.

CONCLUSIONS

Dedicated ICU pharmacists are crucial healthcare team members in a multidisciplinary ICU. In addition to substantially reducing drug costs, they provide continuity in individualized pharmacotherapeutic care, and serve an important educational function.

摘要

目的

描述临床重症监护病房(ICU)药师的工作内容,并确定由药师发起的会诊是否会导致药物费用的变化。

设计

前瞻性3个月研究。

地点

一家拥有15张床位、与大学相关的三级医疗外科ICU。

干预措施

记录了以下ICU药师的工作内容:为医生的询问提供药物信息;为护士的询问提供药物信息;澄清医嘱;药物可及性信息;药代动力学会诊;药物不良反应的检测与报告;以及由药师发起的导致药物治疗改变的治疗会诊。当发生药物治疗改变时,确定改变前后的药物费用。

测量指标与主要结果

在54个工作日期间,共发生了575次药师干预(平均每天10.7±5.0次干预)。最常见的干预是由药师发起的治疗会诊(占总数的44.7%,257/575),以及对医生药物信息请求的回应(占39.0%,224/575)。最耗费资源的活动是为医生提供药物信息和治疗会诊(分别为每天49.6分钟和35.9分钟)。所有干预平均每天花费1.70小时(102分钟)。治疗会诊使药物费用降低(47.1%)、不变(42.0%)或增加(10.9%),3个月内净节省10,010.60加元,如果临床药学服务扩展到每周7天,预计每年可节省67,664.24加元。

结论

在多学科的ICU中,专职的ICU药师是至关重要的医疗团队成员。除了大幅降低药物费用外,他们还能提供个性化药物治疗护理的连续性,并发挥重要的教育作用。

相似文献

1
Impact of a clinical pharmacist in a multidisciplinary intensive care unit.临床药师在多学科重症监护病房中的影响。
Crit Care Med. 1994 Jun;22(6):1044-8. doi: 10.1097/00003246-199406000-00027.
2
Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.儿科临床药师在儿科重症监护病房的影响。
Crit Care Med. 2002 Apr;30(4):919-21. doi: 10.1097/00003246-200204000-00035.
3
Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.将临床药师纳入成人重症监护病房的获益:一项成本节约研究。
J Clin Pharm Ther. 2020 Oct;45(5):1127-1133. doi: 10.1111/jcpt.13195. Epub 2020 Jun 4.
4
Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.临床药师对重症监护病房药物治疗中成本节约和成本规避的影响。
Hosp Pharm. 1994 Mar;29(3):215-8, 221.
5
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.药剂师参与重症监护病房的医师查房及药物不良事件
JAMA. 1999 Jul 21;282(3):267-70. doi: 10.1001/jama.282.3.267.
6
Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.药剂师干预对一所大学教学医院临床结局及成本规避的影响。
Int J Clin Pharm. 2018 Dec;40(6):1474-1481. doi: 10.1007/s11096-018-0733-6. Epub 2018 Oct 26.
7
Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit.药师和护士干预对内科重症监护病房药物治疗费用的影响。
Am J Hosp Pharm. 1989 Jun;46(6):1179-82.
8
Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.重症监护药剂师干预措施的成本影响及预防的潜在不良事件
Am J Health Syst Pharm. 2007 Dec 1;64(23):2483-7. doi: 10.2146/ajhp060674.
9
Inability to justify a part-time clinical pharmacist in a community hospital intensive-care unit.社区医院重症监护病房无法为配备一名兼职临床药剂师提供合理依据。
Am J Hosp Pharm. 1991 Oct;48(10):2154-7.
10
Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups.重症医学中临床药学的预期净效益:一项前后匹配组的随机干预性对照试验。
J Eval Clin Pract. 2014 Dec;20(6):1172-9. doi: 10.1111/jep.12289. Epub 2014 Dec 2.

引用本文的文献

1
Clinical pharmacist-led problem-specific education as a strategy for addressing suboptimal antimicrobial use in intensive care unit: a prospective pre-post analysis.临床药师主导的针对特定问题的教育作为解决重症监护病房抗菌药物使用不合理问题的策略:一项前瞻性前后分析。
Front Pharmacol. 2025 May 26;16:1556884. doi: 10.3389/fphar.2025.1556884. eCollection 2025.
2
PHarmacist Avoidance or Reductions in Medical Costs Considering Board of Pharmacy Specialties Certification (PHARM-BPS).考虑药学专业委员会认证(PHARM-BPS)的药剂师避免或降低医疗成本的情况。
Hosp Pharm. 2025 Feb 13:00185787251319311. doi: 10.1177/00185787251319311.
3
Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network.
在远程重症监护网络中增加重症监护药师的实施情况及影响
Crit Care Explor. 2023 Jan 12;5(1):e0839. doi: 10.1097/CCE.0000000000000839. eCollection 2023 Jan.
4
PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.重症成年患者中药师避免或降低医疗成本:PHARM-CRIT研究
Crit Care Explor. 2021 Dec 10;3(12):e0594. doi: 10.1097/CCE.0000000000000594. eCollection 2021 Dec.
5
Role of pharmacist during COVID-19 pandemic: A retrospective study focused on critically ill COVID-19 patients.药剂师在新冠疫情期间的作用:一项聚焦于危重新冠肺炎患者的回顾性研究。
Saudi Pharm J. 2021 Sep;29(9):1050-1055. doi: 10.1016/j.jsps.2021.07.010. Epub 2021 Jul 16.
6
Voluntarily reported prescribing, monitoring and medication transfer errors in intensive care units in The Netherlands.荷兰重症监护病房自愿报告的处方、监测和药物转用错误。
Int J Clin Pharm. 2021 Feb;43(1):66-76. doi: 10.1007/s11096-020-01101-5. Epub 2020 Aug 19.
7
A new approach on assessing clinical pharmacists' impact on prescribing errors in a surgical intensive care unit.一种评估临床药师在外科重症监护病房处方错误方面影响的新方法。
Int J Clin Pharm. 2019 Oct;41(5):1184-1192. doi: 10.1007/s11096-019-00874-8. Epub 2019 Jul 22.
8
Standards for Neurologic Critical Care Units: A Statement for Healthcare Professionals from The Neurocritical Care Society.神经重症监护病房标准:神经重症监护学会医疗专业人员的声明。
Neurocrit Care. 2018 Oct;29(2):145-160. doi: 10.1007/s12028-018-0601-1.
9
Evaluation of Clinical Pharmacy Services in the Intensive Care Unit of a Tertiary University Hospital in the Northwest of Iran.伊朗西北部一所三级大学医院重症监护病房临床药学服务评估
J Res Pharm Pract. 2018 Jan-Mar;7(1):30-35. doi: 10.4103/jrpp.JRPP_17_82.
10
Critical Care Pharmacists and Medication Management in an ICU Recovery Center.重症监护药师与重症监护病房康复中心的药物管理
Ann Pharmacother. 2018 Aug;52(8):713-723. doi: 10.1177/1060028018759343. Epub 2018 Feb 18.